Amarin aims for Vascepa boom with doubled sales force nearly in place

Amarin aims for Vascepa boom with doubled sales force nearly in place

Source: 
Fierce Pharma
snippet: 

Amarin scored an FDA win with blockbuster potential last year when its fish oil-derivative Vascepa received a heart-helping nod on top of statins. Now, with Amarin's fleshed out sales force nearly in place and prescriptions soaring, the drugmaker is ready to take Vascepa to the next level.